Molecular and biological factors in the prognosis of head and neck squamous cell cancer
- PMID: 37493876
- DOI: 10.1007/s11033-023-08611-1
Molecular and biological factors in the prognosis of head and neck squamous cell cancer
Abstract
The objective of the review is to summarize available literary data on the role and prognostic value of molecular biological markers p53, UBE2C, CD147, STAT3, VEGF in the carcinogenesis of head and neck squamous cell carcinoma (HNSCC). To date, researches have been studying HNSCC molecular and genetic characteristics and obtaining information about new molecular biological markers that have different functional significance in tumor progression. This review presents current data on protein molecules involved in the HNSCC development, as well as in the formation of drug resistance mechanisms in tumors. The considered markers can be used not only for prognosis but also for developing a new approach to treatment, including patients resistant to therapy or recurrent HNSCC. However, the introduction of these markers into practice requires further examination of their functions and larger-scale studies.
Keywords: HNSCC; Molecular markers; Tumor progression.
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
UBE2C promotes the progression of head and neck squamous cell carcinoma.Biochem Biophys Res Commun. 2020 Mar 5;523(2):389-397. doi: 10.1016/j.bbrc.2019.12.064. Epub 2019 Dec 20. Biochem Biophys Res Commun. 2020. PMID: 31870550
-
CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.J Cell Mol Med. 2019 Feb;23(2):954-966. doi: 10.1111/jcmm.13996. Epub 2018 Nov 12. J Cell Mol Med. 2019. PMID: 30421493 Free PMC article.
-
Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.Biomed Res Int. 2021 Feb 10;2021:8824195. doi: 10.1155/2021/8824195. eCollection 2021. Biomed Res Int. 2021. PMID: 33628816 Free PMC article.
-
Role of miRNA in head and neck squamous cell carcinoma.Expert Rev Anticancer Ther. 2015 Feb;15(2):183-97. doi: 10.1586/14737140.2015.978294. Epub 2014 Nov 4. Expert Rev Anticancer Ther. 2015. PMID: 25367254 Review.
-
Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.Nutrients. 2023 May 31;15(11):2592. doi: 10.3390/nu15112592. Nutrients. 2023. PMID: 37299554 Free PMC article. Review.
Cited by
-
Bioinformatics analysis reveals VEGFC's prognostic significance in head and neck squamous cell carcinoma and its association with immune cell infiltration.Transl Cancer Res. 2024 Nov 30;13(11):5953-5970. doi: 10.21037/tcr-24-834. Epub 2024 Nov 27. Transl Cancer Res. 2024. PMID: 39697755 Free PMC article.
-
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.Biomedicines. 2024 Feb 10;12(2):415. doi: 10.3390/biomedicines12020415. Biomedicines. 2024. PMID: 38398017 Free PMC article. Review.
-
Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer.J Pers Med. 2024 Oct 10;14(10):1048. doi: 10.3390/jpm14101048. J Pers Med. 2024. PMID: 39452555 Free PMC article. Review.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018 Nov) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
-
- Reid PA, Wilson P, Li Y, Marcu LG, Bezak E Current understanding of cancer stem cells: review of their radiobiology and role in head and neck cancers. Head Neck 2017 Sep;39(9):1920–1932. https://doi.org/10.1002/hed.24848 . Epub 2017
-
- Global Burden of Disease Cancer Collaboration (2017) Global, Regional, and National Cancer incidence, mortality, years of Life Lost, Years lived with disability, and disability-adjusted life-years for 32 Cancer Groups, 1990 to 2015: a systematic analysis for the global burden of Disease Study. JAMA Oncol 3(4):524–548. https://doi.org/10.1001/jamaoncol.2016.5688 - DOI - PMC
-
- Machiels JP, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V, EHNS Executive Board (2020 Nov) Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(11):1462–1475. https://doi.org/10.1016/j.annonc.2020.07.011
-
- Marur S, Forastiere AA (2016) Mar;91(3):386 – 96 Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc. https://doi.org/10.1016/j.mayocp.2015.12.017
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous